Back to Search
Start Over
Supplementary Data from A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental tables, figures, and methods
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....923b8814f08bb85d26f114b13f180e54